These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 560794)

  • 1. On the role of striatal and nonstriatal dopamine in opiate withdrawal.
    Herz A; Bläsig J; Laschka E; Gramsch C
    Adv Biochem Psychopharmacol; 1977; 16():597-9. PubMed ID: 560794
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of dopamine in withdrawal jumping in morphine dependent rats.
    Bläsig J; Gramsch C; Laschka E; Herz A
    Arzneimittelforschung; 1976; 26(6):1104-6. PubMed ID: 989389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in sensitivity to apomorphine during morphine dependence and withdrawal in rats.
    Cox B; Ary M; Lomax P
    J Pharmacol Exp Ther; 1976 Mar; 196(3):637-41. PubMed ID: 944260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevation of brain dopamine during naloxone-precipitated withdrawal in morphine-dependent mice and rats.
    Iwamoto ET; Ho IK; Way EL
    J Pharmacol Exp Ther; 1973 Dec; 187(3):588-67. PubMed ID: 4797745
    [No Abstract]   [Full Text] [Related]  

  • 5. Circling behavior after narcotic drugs and during naloxone-precipitated abstinence in rats with unilateral nigral lesions.
    Iwamoto ET; Loh HH; Way EL
    J Pharmacol Exp Ther; 1976 Jun; 197(3):503-16. PubMed ID: 945346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral activation induced by D(2)-like receptor stimulation during opiate withdrawal.
    Druhan JP; Walters CL; Aston-Jones G
    J Pharmacol Exp Ther; 2000 Aug; 294(2):531-8. PubMed ID: 10900229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic influence on withdrawal jumping behavior in morphine-dependent mice.
    Tseng LF; Brase DA; Loh HH
    Res Commun Chem Pathol Pharmacol; 1976 Nov; 15(3):435-46. PubMed ID: 1033590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroanatomical and chemical correlates of naloxone-precipitated withdrawal.
    Way EL; Loh HH; Ho IK; Iwamoto ET; Wei E
    Adv Biochem Psychopharmacol; 1973; 8(0):455-69. PubMed ID: 4604812
    [No Abstract]   [Full Text] [Related]  

  • 9. Nigro-neostriatal dopaminergic activity and axonal protein transport during morphinization and withdrawal in rats.
    Iwamoto ET; Craves RB; Loh HH; Meyerhof J; Way EL
    Proc West Pharmacol Soc; 1975; 18():288-93. PubMed ID: 1237141
    [No Abstract]   [Full Text] [Related]  

  • 10. Tetrahydrocannabinol-attenuated abstinence and induced rotation in morphine-dependent rats: possible involvement of dopamine.
    Hine B; Friedman E; Torrelio M; Gershon S
    Neuropharmacology; 1975 Aug; 14(8):607-10. PubMed ID: 1237098
    [No Abstract]   [Full Text] [Related]  

  • 11. Adaptive cholinergic-dopaminergic responses in morphine dependence.
    Way EL; Iwamoto ET; Bhargava HN; Loh HH
    Adv Biochem Psychopharmacol; 1975; 13():169-84. PubMed ID: 1171581
    [No Abstract]   [Full Text] [Related]  

  • 12. Activity of the nigro-striatal dopaminergic system during precipitated morphine withdrawal investigated in rats with acute unilateral inactivation of the striatum.
    Laschka E; Herz A; Bläsig J
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Dec; 296(1):15-23. PubMed ID: 1034882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dynamics of hippocampal sensory gating during the development of morphine dependence and withdrawal in rats.
    Zheng J; Yang Y; Tian S; Chen J; Wilson FA; Ma Y
    Neurosci Lett; 2005 Jul 1-8; 382(1-2):164-8. PubMed ID: 15911142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in cerebral dopamine function induced by a year's administration of trifluoperazine or thioridazine and their subsequent withdrawal.
    Clow A; Theodorou A; Jenner P; Marsden CD
    Adv Biochem Psychopharmacol; 1980; 24():335-40. PubMed ID: 7190762
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on dopamine kinetics in rat brain tissue under the influence of morphine.
    Kuschinsky K; Celsen B; Huppertz A
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):129-33. PubMed ID: 1172489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enkephalinase inhibitors attenuate naloxone-precipitated withdrawal syndrome.
    Dzoljic MR
    NIDA Res Monogr; 1986; 75():575-8. PubMed ID: 3123978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central sites of naloxone-precipitated shaking in the anesthetized, morphine-dependent rat.
    Wei E; Sigel SS; Loh HH; Way EL
    J Pharmacol Exp Ther; 1975 Dec; 195(3):480-7. PubMed ID: 1238555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of chronic met-enk on various dopamine systems in the rat.
    Steece KA; DeLeon-Jones FA; Lee JM; Ritzmann RF
    NIDA Res Monogr; 1986; 75():583-6. PubMed ID: 3123979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of brain and spinal cord dopamine D1 receptors labeled with [3H]SCH 23390 after morphine withdrawal from tolerant and physically dependent rats.
    Bhargava HN; Gulati A
    J Pharmacol Exp Ther; 1990 Mar; 252(3):901-7. PubMed ID: 2138669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of phentolamine on blood pressure, heart rate and plasma catecholamine levels in conscious, unrestrained morphine dependent rats during naloxone precipitated autonomic withdrawal responses.
    Dixon WR; Chang AP
    Proc West Pharmacol Soc; 1988; 31():117-9. PubMed ID: 3211890
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.